EUCTR2019-001575-37-IT进行中（未招募）1 期
ong-term follow-up of adult Philadelphia chromosome negative acute lymphoblastic leukemia relapsed refractory patients enrolled in Study 00103311 - NA
AMGEN INC.0 个研究点目标入组 75 人开始时间: 2021年5月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients who were enrolled originally in the 00103311 trial (A Phase 3, Randomized, Open Label Study Investigating the Efficacy of the BiTE Antibody Blinatumomab Versus Standard of Care Chemotherapy in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (TOWER Study)).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 80
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 28
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
ong-term follow-up of adult patients previously enrolled in Study 00103311 with a type of acute lymphoblastic leukemia that did not respond to previous therapy or that relapsed after initially successful previous therapyAdult patients with relapsed and/or refractory B-precursor acute lymphoblastic leukaemialastic leukaemiaMedDRA version: 21.0Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10063625Term: Acute lymphoblastic leukemia recurrentSystem Organ Class: 100000004864EUCTR2019-001575-37-DEAmgen Inc.108
招募中
3 期
The study aims to verify the greater efficacy of the treatment of Acute Lymphoblastic Leukemia Ph + through the combination of Ponatinib and Blinatumomab, a specific monoclonal antibody, in adult patients, compared to the administration of chemotherapy and Imatinib. ALL28202023-508968-30-00Fondazione Gimema Franco Mandelli Onlus236
进行中（未招募）
1 期
ational Treatment Program of Philadelphia Chromosome-negative Adult Acute Lymphoblastic Leukemia with Pegylated Asparaginase Added to a Lineage-Targeted Risk- and Minimal Residual Disease-Oriented Strategyational Treatment Program of Philadelphia Chromosome-negative Adult Acute Lymphoblastic Leukemia with Pegylated Asparaginase added to a Lineage-Targeted Risk- and Minimal Residual Disease-Oriented StrategyEUCTR2014-000383-18-ITG.I.M.EM.A. Gruppo Italiano Malattie EMatologiche dell'Adulto204
招募中
不适用
ong term follow up of the clinical and immunological responses following HPV 16 E6/E7 synthetic long peptides vaccination in women with HPV 16 positive vulvar intraepithelial neoplasia grade 3VINvulvair intraepithelial neoplasia10038594NL-OMON36101eids Universitair Medisch Centrum19
招募中
不适用
ong term follow-up protocol of prospective cohort study on bone mineral density changes in the stage 1 or 2 gastric cancer patients after gastrectomygastric cancerJPRN-UMIN000043647Kindai University170